Merck's most recent trend suggests a bearish bias. One trading opportunity on Merck is a Bear Call Spread using a strike $55.00 short call and a strike $60.00 long call offers a potential 22.85% return on risk over the next 33 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $55.00 by expiration. The full premium credit of $0.93 would be kept by the premium seller. The risk of $4.07 would be incurred if the stock rose above the $60.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Merck is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Merck is bearish.
The RSI indicator is at 29.36 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Merck
Dow Jones (DJIA) Today: Merck (MRK) Higher
Mon, 20 Oct 2014 17:00:00 GMT
8:04 am Merck: US FDA accepts for review a biologics license application for Merck and Sanofi (SNY) Pasteur's investigational pediatric hexavalent vaccine
Mon, 20 Oct 2014 12:04:00 GMT
Award-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goals
Mon, 20 Oct 2014 12:00:00 GMT
PR Newswire – WHITEHOUSE STATION, N.J., Oct. 20, 2014 /PRNewswire/ — Merck (MRK), known as MSD outside the United States and Canada, and actress S. Epatha Merkerson are bringing the America's Diabetes Challenge: Get to Your Goals program to Atlanta, Georgia to encourage African Americans with type 2 diabetes to know their A1C—their average blood sugar level over the past two to three months—and talk to their doctors about setting and attaining a personal A1C goal. Merkerson, one of the 4.9 million African-American adults living with diabetes, will attend the American Diabetes Association's Live Empowered event in Atlanta, Georgia at Victory World Church on October 20 to share her story.
US FDA Accepts for Review a Biologics License Application for Merck and Sanofi Pasteur’s Investigational Pediatric Hexavalent Vaccine
Mon, 20 Oct 2014 12:00:00 GMT
Business Wire – Merck , known as MSD outside the United States and Canada, and Sanofi Pasteur, the vaccines division of Sanofi , announced today that the Biologics License Application filed for the companies’ investigational pediatric hexavalent vaccine, DTaP5-IPV-Hib-HepB1, has been accepted for review by the U.S.
Roche, Merck extend immunotherapy fight to breast cancer
Fri, 17 Oct 2014 06:41:05 GMT
Related Posts
Also on Market Tamer…
Follow Us on Facebook